291 results on '"Solves, Pilar"'
Search Results
2. Hospital variation in quality indicators for patient blood management in total knee and hip arthroplasty: a retrospective cohort study
3. Incidence, Risk Factors and Therapy Response of Acute Graft-versus-Host Disease after Postransplant Cyclophosphamide
4. Cytomegalovirus Reactivations in Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Matched and Haploidentical Donors with Post-Transplantation Cyclophosphamide
5. Selective IgA Deficiency and Blood Component Transfusion: In Search of the Lost Evidence
6. Reduced Incidence of Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Calcineurin-Free Graft-versus-Host Disease Prophylaxis
7. Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question
8. Transfusion management in multiple myeloma patients receiving daratumumab: Experience of a single tertiary care centre
9. Partial T Cell-Depleted Peripheral Blood Stem Cell Transplantation from HLA-Identical Sibling Donors for Patients with Severe Aplastic Anemia
10. Autologous Platelet-Rich Plasma: Is it the Best Choice to Treat Degenerative Pathologies in the Elderly?
11. T Cell-Depleted Peripheral Blood versus Unmanipulated Bone Marrow in Matched Sibling Transplantation for Aplastic Anemia
12. Impact of Post-Transplantation Cyclophosphamide on Transfusion Requirements in HLA-Matched Sibling Peripheral Blood Stem Cell Transplantation
13. Noninfectious Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation
14. Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis
15. Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain
16. Transfusion Burden in Allogeneic Hematopoietic Stem Cell Transplantation over Time: Experience from a Single Institution
17. Longitudinal outcome over four decades of allogeneic stem cell transplantation: a single center experience
18. Central Nervous System Involvement in Epstein–Barr Virus-Related Post-Transplant Lymphoproliferative Disorders after Allogeneic Hematopoietic Stem Cell Transplantation
19. Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation
20. IMPACT OF POSTTRANSPLANT CYCLOPHOSPHAMIDE ON TRANSFUSION REQUIREMENTS IN HLA MATCHED SIBLING PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
21. Cryopreservation of Hematopoietic Stem Cells from Umbilical Cord Blood for Transplantation
22. Effect of CD8+ Cell Content on Umbilical Cord Blood Transplantation in Adults with Hematological Malignancies
23. Cord Blood as a Source of Hematopoietic Progenitors for Transplantation
24. Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients
25. Results of a preoperative autologous blood donation program for patients undergoing elective major spine surgery
26. Acute hemolytic reaction by anti-Wra: Case report and review of the hemovigilance database of a tertiary care hospital
27. ACUTE HEMOLYTIC REACTION BY ANTI-Wra: CASE REPORT AND REVIEW OF THE HEMOVIGILANCE DATABASE OF A TERTIARY CARE HOSPITAL
28. A new automatic device for routine cord blood banking: critical analysis of different volume reduction methodologies
29. Extracorporeal photopheresis vs standard therapies for steroid‐refractory chronic graft‐vs‐host disease: Pharmacoeconomic assessment of hospital resource use in Spain
30. International Forum on Transfusion Practices in Haematopoietic Stem‐Cell Transplantation: Responses
31. International Forum on Transfusion Practices in Haematopoietic Stem‐Cell Transplantation: Summary
32. Influence of volume reduction and cryopreservation methodologies on quality of thawed umbilical cord blood units for transplantation
33. Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues
34. Adoptive transfer of ex vivo expanded SARS‐CoV‐2‐specific cytotoxic lymphocytes: A viable strategy for COVID‐19 immunosuppressed patients?
35. Cryopreservation of Hematopoietic Stem Cells from Umbilical Cord Blood for Transplantation
36. Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question
37. Ex vivo T‐cell depletion vs post‐transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft‐vs‐host disease prophylaxis for allogeneic hematopoietic stem cell transplantation
38. Contributors
39. Stem Cell Banking
40. Cord Blood as a Source of Hematopoietic Progenitors for Transplantation
41. Cord blood quality after vaginal and cesarean deliveries
42. Viable hematopoietic progenitor cells in frozen femoral heads from living donors for orthopedic surgery
43. Platelet transfusion in the real life
44. Clinical Characteristics and Transfusion Management of Patients Diagnosed of Multiple Myeloma Receiving Daratumumab: Experience of a Single Centre
45. Presence of meconium-stained amniotic fluid in cesarean deliveries increases the total nucleated cell content of umbilical cord blood units
46. A broken cord blood bag: placing the unit in a sterile zip-lock bag before thawing prevents catastrophic events
47. Stress factors and umbilical cord blood banking
48. CD34+ cell content for selecting umbilical cord blood units for cryopreservation
49. The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation
50. Unrelated Cord Blood Banking and Transplantation: Implications for Obstetricians
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.